T1	Participants 275 287	30 patients)
T2	Participants 260 274	control group,
T3	Participants 404 474	55 patients with malignant pleural effusion due to primary lung cancer
T4	Participants 351 362	26 patients
T5	Participants 364 403	with tube thoracostomy was performed in
T6	Participants 857 913	Twenty-four patients with malignant pericardial effusion
